fixed swr [RSABE / ABEL]

posted by martin  – Austria, 2013-03-29 16:07 (4016 d 17:05 ago) – Posting: # 10311
Views: 19,755

Hi Helmut !

Yep; your are totally right (should have done my homework first ;-)). what about defining the extent of scaling after interim analysis of the first stage data (CV estimated in 1st stage) within a group-sequential adaptive design?

Drawback: BUT what if the CV at interim is smaller than 0.3 ... :confused:

best regards

martin

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,641 registered users;
43 visitors (0 registered, 43 guests [including 9 identified bots]).
Forum time: 09:12 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5